On October 15, Astera Labs, Inc. fell 3.72% in Pre-Market Trading, trading at $289.2299 per share, with turnover of $4.0336 million.
The clearest catalyst remains the recent rating downgrade by Northland Securities to market perform from outperform, while profit-taking pressure has persisted ahead of the company’s November 3 third-quarter results.
Recent market updates showed the stock already under pressure across prior pre-market, regular, and after-hours sessions for the same reason, indicating the downgrade has continued to weigh on near-term sentiment. At the same time, consensus expectations cited in recent coverage were not materially weaker, with analysts still carrying an average overweight-style view and a mean target price of $416.78, while the next-quarter EPS expectation stood at $0.83.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments